These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23712607

  • 1. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H, Liu H, Knauss JL.
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [Abstract] [Full Text] [Related]

  • 2. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC.
    PLoS One; 2013 Oct; 8(1):e55597. PubMed ID: 23383237
    [Abstract] [Full Text] [Related]

  • 3. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W, Liu L, Yin Z, Guan P, Li X, Zhou B.
    PLoS One; 2014 Oct; 9(1):e86798. PubMed ID: 24497981
    [Abstract] [Full Text] [Related]

  • 4. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
    He LW, Shi R, Jiang L, Zeng Y, Ma WL, Zhou JY.
    PLoS One; 2014 Oct; 9(11):e111981. PubMed ID: 25375625
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
    Zhang H, Liu H, Jiang G.
    PLoS One; 2013 Oct; 8(11):e80687. PubMed ID: 24363792
    [Abstract] [Full Text] [Related]

  • 6. Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China.
    Xu G, Wang M, Xie W, Bai X.
    Tumour Biol; 2014 Feb; 35(2):1389-95. PubMed ID: 24048757
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population.
    Fan SC, Zhou JG, Yin JZ.
    Genet Mol Res; 2016 Aug 26; 15(3):. PubMed ID: 27706616
    [Abstract] [Full Text] [Related]

  • 8. XRCC1 and XRCC3 variants and risk of glioma and meningioma.
    Kiuru A, Lindholm C, Heinävaara S, Ilus T, Jokinen P, Haapasalo H, Salminen T, Christensen HC, Feychting M, Johansen C, Lönn S, Malmer B, Schoemaker MJ, Swerdlow AJ, Auvinen A.
    J Neurooncol; 2008 Jun 26; 88(2):135-42. PubMed ID: 18330515
    [Abstract] [Full Text] [Related]

  • 9. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M, Zhou X, Ding X, Wei L, Zhao Y, Zhu T, Shi X, Qin D.
    Rheumatol Int; 2017 Mar 26; 37(3):435-444. PubMed ID: 27812739
    [Abstract] [Full Text] [Related]

  • 10. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T, Wang ZG, Zhang JL, Liu H.
    World J Gastroenterol; 2012 Aug 21; 18(31):4207-14. PubMed ID: 22919255
    [Abstract] [Full Text] [Related]

  • 11. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
    Zhou X, Gu L, Zeng Y, Wei L, Ying M, Wang N, Su C, Wang Y, Liu C.
    Tumour Biol; 2014 Nov 21; 35(11):10665-76. PubMed ID: 25062722
    [Abstract] [Full Text] [Related]

  • 12. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y, Liu F, Tan SQ, Wang Y, Li SW.
    PLoS One; 2012 Nov 21; 7(9):e44441. PubMed ID: 22984511
    [Abstract] [Full Text] [Related]

  • 13. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
    Li S, Deng Y, You JP, Chen ZP, Peng QL, Huang XM, Lu QH, Huang XL, Zhao JM, Qin X.
    Dig Dis Sci; 2013 Jul 21; 58(7):1880-90. PubMed ID: 23543084
    [Abstract] [Full Text] [Related]

  • 14. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
    Gu X, Sun H, Chang L, Sun R, Yang H, Zhang X, Cong X.
    Neural Regen Res; 2013 Sep 15; 8(26):2468-77. PubMed ID: 25206557
    [Abstract] [Full Text] [Related]

  • 15. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S, Wu S, Wang M.
    Technol Cancer Res Treat; 2021 Sep 15; 20():15330338211033060. PubMed ID: 34278875
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
    Zhu W, Yao J, Li Y, Xu B.
    Tumour Biol; 2014 Apr 15; 35(4):3061-6. PubMed ID: 24258108
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.
    Zhang XQ, Li L.
    Medicine (Baltimore); 2021 Dec 17; 100(50):e28030. PubMed ID: 34918657
    [Abstract] [Full Text] [Related]

  • 18. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
    Zhao DY, Cheng L, Yu J, Shen H.
    Cancer Biomark; 2014 Dec 17; 14(6):449-56. PubMed ID: 25335737
    [Abstract] [Full Text] [Related]

  • 19. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
    Ma WQ, Han XQ, Wang X, Wang Y, Zhu Y, Liu NF.
    PLoS One; 2016 Dec 17; 11(11):e0166961. PubMed ID: 27870881
    [Abstract] [Full Text] [Related]

  • 20. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Li C, Xiang X, Zhou Y.
    Mol Biol Rep; 2014 Nov 17; 41(11):7613-21. PubMed ID: 25086624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.